| Literature DB >> 24766179 |
R J Mash1, H Rhode, M Zwarenstein, S Rollnick, C Lombard, K Steyn, N Levitt.
Abstract
AIM: To evaluate the effectiveness of group education, led by health promoters using a guiding style, for people with type 2 diabetes in public sector community health centres in Cape Town.Entities:
Mesh:
Year: 2014 PMID: 24766179 PMCID: PMC4232864 DOI: 10.1111/dme.12475
Source DB: PubMed Journal: Diabet Med ISSN: 0742-3071 Impact factor: 4.359
Figure 1Flowchart of study groups.
Clinical profile of the study population at baseline
| Control group | Intervention group | |
|---|---|---|
| Mean ( | 56.4 (11.6) | 55.8 (11.5) |
| Mean ( | 78 | 74 |
| Mean ( | 9.3 (2.3) | 8.9 (2.3) |
| Mean ( | 4.9 (1.3) | 5.0 (1.1) |
| Mean ( | 83.9 (18.5) | 84.4 (18.7) |
| Mean ( | 100.3 (14.1) | 101.9 (14.1) |
| Mean ( | 85.4 (13.0) | 85.9 (11.7) |
| Mean ( | 137.2 (24.3) | 140.2 (22.4) |
| Male | 209 (24.3) | 202 (28.5) |
| Female | 650 (75.7) | 508 (71.5) |
| HbA1c < 53 mmol/mol (7%) | 134 (15.6) | 141 (19.9) |
| Cholesterol < 5.0 mmol/l | 458 (53.3) | 342 (48.2) |
| Diastolic blood pressure < 80 mmHg | 289 (33.6) | 212 (29.9) |
| Systolic blood pressure < 130 mmHg | 345 (40.1) | 245 (34.5) |
| Waist circumference: women, < 82 cm | 40/650 (6.2) | 32/508 (6.3) |
| Waist circumference: men, < 94 cm | 80/209 (38.3) | 57/202 (28.2) |
| Hypertension | 715 (83.1) | 539 (75.9) |
| Hypercholesterolaemia | 279 (32.4) | 239 (33.7) |
| Chronic kidney disease | 26 (3.0) | 12 (1.7) |
| Cataracts | 83 (9.7) | 67 (9.4) |
| Retinopathy | 5 (0.6) | 40 (5.6) |
| Peripheral vascular disease | 1 (0.1) | 13 (1.8) |
| Leg ulcers | 36 (4.2) | 24 (3.4) |
| Neuropathy | 12 (1.4) | 52 (7.3) |
| Amputation | 7 (0.8) | 8 (1.1) |
| Ischaemic heart disease | 26 (3.0) | 22 (3.1) |
| Cardiac failure | 35 (4.1) | 4 (0.6) |
| Stroke | 26 (3.0) | 20 (2.8) |
| Metformin | 738 (85.8) | 595 (83.8) |
| Glibenclamide | 115 (13.4) | 118 (16.6) |
| Gliclazide | 324 (37.7) | 268 (37.7) |
| Insulin | 228 (26.5) | 213 (30.0) |
| Hydrochlorthiazide | 438 (50.9) | 337 (47.5) |
| Enalapril | 492 (57.2) | 420 (59.2) |
| Amlodipine | 288 (33.5) | 276 (38.9) |
| Simvastatin | 271 (31.5) | 258 (36.3) |
Self-care activities, psychological factors and quality of life at baseline
| Control group, | Intervention group, | |
|---|---|---|
| Use of diet plan, days/week | 4.7 (2.0) | 4.0 (2.2) |
| Exercise, days/week | 3.0 (2.3) | 3.5 (2.4) |
| Foot care, days/week | 5.6 (2.1) | 4.7 (2.6) |
| Use of medication, days/week | 6.9 (0.5) | 6.7 (1.2) |
| Smokers, | 157 (18.3) | 130 (18.3) |
| Self-efficacy (scale 1–10) | 3.4 (0.6) | 3.5 (0.7) |
| Internal locus of control (scale 1–6) | 4.8 (0.6) | 4.7 (0.8) |
| External locus of control (scale 1–6) | 4.4 (0.6) | 4.2 (0.9) |
| Chance locus of control (scale 1–6) | 3.7 (1.1) | 3.4 (1.2) |
| Physical functioning | 77.4 (20.8) | 74.8 (21.3) |
| Role functioning | 72.5 (27.9) | 79.2 (26.5) |
| Social functioning | 59.1 (28.3) | 65.9 (32.2) |
| Mental status | 60.2 (11.6) | 59.3 (14.3) |
| Health status | 56.8 (10.8) | 56.5 (13.9) |
| Pain | 53.6 (27.6) | 57.9 (28.1) |
Results for primary and secondary outcomes
| Outcomes | Control group, | Intervention group, | Difference: intervention – control (95% CI) | |
|---|---|---|---|---|
| Physical activity | 4.0 (2.6) | 3.9 (2.3) | -0.25 (-1.13 – 0.63) | 0.574 |
| Use of diet plan | 4.8 (2.2) | 4.6 (2.1) | -0.08 (-0.69 – 0.53) | 0.802 |
| Use of medication | 6.9 (0.9) | 6.8 (0.8) | 0.01 (-0.13 – 0.15) | 0.897 |
| Foot care | 5.7 (1.8) | 5.5 (2.1) | -0.14 (-0.46 – 0.17) | 0.380 |
| Smoking, | 99/483 (20.5) | 78/409 (19.1) | -0.4 (-3.6 to 2.8) | 0.800 |
| Self-efficacy | 3.7 (0.6) | 3.7 (0.6) | -0.03 (-0.19 – 0.13) | 0.735 |
| Internal locus of control | 4.8 (0.5) | 4.8 (0.5) | 0.02 (-0.09 – 0.13) | 0.711 |
| External locus of control | 4.5 (0.6) | 4.4 (0.6) | 0.08 (-0.24 – 0.19) | 0.283 |
| Chance locus of control | 3.8 (1.1) | 3.6 (1,1) | -0.18 (-0.56 – 0.19) | 0.344 |
| HbA1c, mmol/mol | 71 | 68 | ||
| HbA1c,% | 8.8 (2.2) | 8.4 (2.0) | 0.01 (-0.27 – 0.28) | 0.967 |
| Weight, kg | 83.5 (18.3) | 83.8 (20.2) | -1.01 (-3.32 – 1.30) | 0.392 |
| Waist circumference, cm | 103.1 (13.1) | 103.6 (15.5) | -0.72 (-2.4 – 0.94) | 0.396 |
| Systolic blood pressure, mmHg | 146.1 (24.6) | 143.1 (24.2) | -4.65 (-9.18 – -0.12) | 0.044 |
| Diastolic blood pressure, mmHg | 88.2 (12.8) | 85.0 (11.9) | -3.30 (-5.35 - -1.26) | 0.002 |
| Total cholesterol, mmol/l | 4.9 (1.2) | 4.8 (1.1) | -0.13 (-0.27 – 0.01) | 0.066 |
| Physical functioning | 26.9 (6.0) | 26.4 (6.1) | -0.34 (-1.87- 1.20) | 0.668 |
| Role functioning | 79.1 (26.4) | 81.7 (25.6) | 2.05 (-3.95 – 8.05) | 0.503 |
| Social functioning | 63.7 (30.4) | 63.2 (30.8) | -0.34 (-10.89 – 10.21) | 0.950 |
| Mental health | 60.2 (13.2) | 60.1 (13.7) | -0.08 (-3.86-3.70) | 0.966 |
| General health | 60.0 (11.4) | 58.8 (10.8) | -1.24 (-3.03 – 0.57) | 0.179 |
| Pain | 56.0 (30.5) | 57.7 (29.9) | 0.06 (-5.96- 6.08) | 0.984 |
The mean values for control and intervention in Table3 are the unweighted mean values of the participants who completed the follow-up, whereas the differences reported use the weighted means as per the analysis model.